We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
-23.28%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$275M
AUM Growth
-$206M
Cap. Flow
-$93.2M
Cap. Flow %
-33.92%
Top 10 Hldgs %
100%
Holding
11
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 88.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
$88.8M 32.32%
4,592,047
ABMD
2
DELISTED
Abiomed Inc
ABMD
$78.2M 28.48%
3,150,000
CORI
3
DELISTED
Corium International, Inc.
CORI
$57.4M 20.91%
9,353,304
ELGX
4
DELISTED
Endologix Inc
ELGX
$31.6M 11.52%
251,494
-30,000
-11% -$4.18M
ACUR
5
DELISTED
Acura Pharmaceuticals
ACUR
$7.63M 2.78%
2,056,977
TCRT icon
6
Alaunos Therapeutics
TCRT
$4.84M
$7.13M 2.6%
18,433
MNOV icon
7
MediciNova
MNOV
$65M
$3.5M 1.27%
1,170,370
CRIS icon
8
Curis
CRIS
$7.13M
$330K 0.12%
117
PTN
9
Palatin Technologies
PTN
$13.1M
$23K 0.01%
19
ECTE
10
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$10K ﹤0.01%
12,319
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-5,815,940
Closed -$89M

Similar funds

Essex Woodlands Management's Q3 2014 Portfolio in Review

As of Q3 2014, Essex Woodlands Management held 11 positions worth $275M, down 43% from $481M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management withdrew a net $93.2M in Q3 2014, closing 1 position and reducing 1 holding. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 88% a quarter earlier.

  • Essex Woodlands Management's biggest Q3 2014 reduction was Endologix Inc, cutting an estimated $4.18M.
  • Essex Woodlands Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014, selling an estimated $89M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $275M portfolio in Q3 2014.
  • Essex Woodlands Management opened 0 new positions and closed 1 in Q3 2014.
  • Essex Woodlands Management's portfolio value fell 43% quarter-over-quarter to $275M.

Based on Essex Woodlands Management's 13F filing for Q3 2014, filed 14 Nov 2014.